B. W. Roush

发表

Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 2. In vitro and in vivo studies with 2,3-dichloro- -methylbenzylamine.

R. Fuller, H. Snoddy, B. Molloy, 1973, Journal of medicinal chemistry.

Substrates and inhibitors of phenyletholamine n-methyl transferase from human adrenal glands

R. Fuller, B. W. Roush, 1972 .

Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 1. Structure-activity relationships.

R. Fuller, W. Day, M. Marsh, 1973, Journal of medicinal chemistry.

The effects of quipazine on serotonin metabolism in rat brain.

D. Wong, K. Perry, F. Bymaster, 1976, Life sciences.

Regulation of phenylethanolamine N-methyl transferase.

R. Fuller, B. Molloy, B. W. Roush, 1974, Advances in enzyme regulation.

Binding of tryptophan to plasma proteins in several species.

R. Fuller, B. W. Roush, 1973, Comparative biochemistry and physiology. B, Comparative biochemistry.

5,6-Dihydroxytryptamine is a substrate for catechol O-methyltransferase.

R. Fuller, B. W. Roush, 1974, Biochemical pharmacology.

Disposition and behavioral effects of amphetamine and , -difluoroamphetamine in mice.

R. Fuller, B. Molloy, B. W. Roush, 1972, Biochemical pharmacology.

Further structure-activity studies on the lowering of brain 5-hydroxyindoles by 4-chloramphetamine.

R. Fuller, H. Snoddy, B. Molloy, 1973, Neuropharmacology.

Substrate-selective and tissue-selective inhibition of monoamine oxidase.

R. Fuller, B. W. Roush, 1972, Archives internationales de pharmacodynamie et de therapie.

Drug disposition as a factor in the lowering of brain serotonin by chloroamphetamines in the rat.

R. Fuller, R. Schaffer, B. Molloy, 1972, Biochemical pharmacology.